Category

Beta2-agonists Use during Pregnancy and Congenital Malformations

 

Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

 
₹ 5,066

Availability: Out of stock

 

Delivery :

Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description
 

According to asthma management guidelines during pregnancy, short-acting ?2-agonists (SABA) are the drug of choice in all types of asthma [intermittent or persistent, mild, moderate and severe] as a quick reliever medication and in the management of acute exacerbations or emergency hospitalizations. On the other hand, long-acting ?2-agonists (LABA) are used for patients with moderate and severe persistent asthma not fully controlled with inhaled corticosteroids alone. While many studies examined their associations with congenital malformations in newborns, the actual risks remain controversial due to the discordance between different risk reports and the difficulties in performing epidemiological studies on pregnant women. The objective of this research is to investigate the association between maternal exposure to SABA and LABA during the first trimester of pregnancy and the risk of congenital malformations in the newborns among asthmatic women.

Product Specifications
SKU :COC31053
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
0 Review(s)